Fan Zhang
Auto-generated profile, based on publicly available information

Fan Zhang

Division of Rheumatology, University of Colorado Anschutz School of Medicine, Aurora, USA

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2019 in Nature Methods
Verified
Journal Article
Closed access
PDF file
IKIlya Korsunsky
Ilya Korsunsky
NMNghia Millard
Nghia Millard
JFJean Fan
Jean Fan
KSKamil Slowikowski
Kamil Slowikowski
FZFan Zhang
Fan Zhang
SRSoumya Raychaudhuri
Soumya Raychaudhuri

6 May 2019 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
Eddie A. JamesEddie A. James
Eddie A. James
FZFan Zhang
Fan Zhang
KWKevin Wei
Kevin Wei
KSKamil Slowikowski
Kamil Slowikowski
CFChamith Y. Fonseka
Chamith Y. Fonseka
SRSoumya Raychaudhuri
Soumya Raychaudhuri

17 June 2019 in Nature Immunology
Verified
Journal Article
Open access
PDF file
TNthe Accelerating Medicines Partnership in SLE network
the Accelerating Medicines Partnership in SLE network
AAArnon Arazi
Arnon Arazi
DRDeepak A. Rao
Deepak A. Rao
CBCeline C. Berthier
Celine C. Berthier
ADAnne Davidson
Anne Davidson
BDBetty Diamond
Betty Diamond
Lupus nephritis is a potentially fatal autoimmune disease for which the current treatment is ineffective and often toxic. To develop mechanistic hypotheses of disease, we analyzed kidney samples from patients with lupus nephritis and from healthy control subjects using single-cell RNA sequencing. Our analysis revealed 21 subsets of leukocytes active in disease, including multiple populations of myeloid cells, T cells, natural killer cells and B cells that demonstrated both pro-inflammatory responses and inflammation-resolving responses. We found evidence of local activation of B cells correlated with an age-associated B-cell signature and evidence of progressive stages of monocyte differentiation within the kidney. A clear interferon response was observed in most cells. Two chemokine receptors, CXCR4 and CX3CR1, were broadly expressed, implying a potentially central role in cell trafficking. Gene expression of immune cells in urine and kidney was highly correlated, which would suggest that urine might serve as a surrogate for kidney biopsies.

8 November 2023 in Nature
Verified
Journal Article
Open access
PDF file
FZFan Zhang
Fan Zhang
AJAnna Helena Jonsson
Anna Helena Jonsson
ANAparna Nathan
Aparna Nathan
NMNghia Millard
Nghia Millard
MCMichelle Curtis
Michelle Curtis
ZZZhu Zhu
Zhu Zhu
Rheumatoid arthritis is a prototypical autoimmune disease that causes joint inflammation and destruction1. There is currently no cure for rheumatoid arthritis, and the effectiveness of treatments varies across patients, suggesting an undefined pathogenic diversity1,2. Here, to deconstruct the cell states and pathways that characterize this pathogenic heterogeneity, we profiled the full spectrum of cells in inflamed synovium from patients with rheumatoid arthritis. We used multi-modal single-cell RNA-sequencing and surface protein data coupled with histology of synovial tissue from 79 donors to build single-cell atlas of rheumatoid arthritis synovial tissue that includes more than 314,000 cells. We stratified tissues into six groups, referred to as cell-type abundance phenotypes (CTAPs), each characterized by selectively enriched cell states. These CTAPs demonstrate the diversity of synovial inflammation in rheumatoid arthritis, ranging from samples enriched for T and B cells to those largely lacking lymphocytes. Disease-relevant cell states, cytokines, risk genes, histology and serology metrics are associated with particular CTAPs. CTAPs are dynamic and can predict treatment response, highlighting the clinical utility of classifying rheumatoid arthritis synovial phenotypes. This comprehensive atlas and molecular, tissue-based stratification of rheumatoid arthritis synovial tissue reveal new insights into rheumatoid arthritis pathology and heterogeneity that could inform novel targeted treatments.

15 June 2022 in Science Translational Medicine
Verified
Journal Article
Closed access
AJAnna Helena Jonsson
Anna Helena Jonsson
FZFan Zhang
Fan Zhang
GDGarrett Dunlap
Garrett Dunlap
EGEmma Gomez-Rivas
Emma Gomez-Rivas
GWGerald F. M. Watts
Gerald F. M. Watts
MBMichael B. Brenner
Michael B. Brenner
T cell–derived pro-inflammatory cytokines are a major driver of rheumatoid arthritis (RA) pathogenesis. Although these cytokines have traditionally been attributed to CD4 T cells, we have found that CD8 T cells are notably abundant in synovium and make more interferon (IFN)–γ and nearly as much tumor necrosis factor (TNF) as their CD4 T cell counterparts. Furthermore, using unbiased high-dimensional single-cell RNA-seq and flow cytometric data, we found that the vast majority of synovial tissue and synovial fluid CD8 T cells belong to an effector CD8 T cell population characterized by high expression of granzyme K (GzmK) and low expression of granzyme B (GzmB) and perforin. Functional experiments demonstrate that these GzmK + GzmB + CD8 T cells are major cytokine producers with low cytotoxic potential. Using T cell receptor repertoire data, we found that CD8 GzmK + GzmB + T cells are clonally expanded in synovial tissues and maintain their granzyme expression and overall cell state in blood, suggesting that they are enriched in tissue but also circulate. Using GzmK and GzmB signatures, we found that GzmK-expressing CD8 T cells were also the major CD8 T cell population in the gut, kidney, and coronavirus disease 2019 (COVID-19) bronchoalveolar lavage fluid, suggesting that they form a core population of tissue-associated T cells across diseases and human tissues. We term this population tissue-enriched expressing GzmK or T teK CD8 cells. Armed to produce cytokines in response to both antigen-dependent and antigen-independent stimuli, CD8 T teK cells have the potential to drive inflammation.

8 May 2019 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
DKDavid Kuo
David Kuo
JDJennifer Ding
Jennifer Ding
ICIan S. Cohn
Ian S. Cohn
FZFan Zhang
Fan Zhang
KWKevin Wei
Kevin Wei
LDLaura Donlin
Laura Donlin
Macrophages tailor their function according to the signals found in tissue microenvironments, assuming a wide spectrum of phenotypes. A detailed understanding of macrophage phenotypes in human tissues is limited. Using single-cell RNA sequencing, we defined distinct macrophage subsets in the joints of patients with the autoimmune disease rheumatoid arthritis (RA), which affects ~1% of the population. The subset we refer to as HBEGF+ inflammatory macrophages is enriched in RA tissues and is shaped by resident fibroblasts and the cytokine tumor necrosis factor (TNF). These macrophages promoted fibroblast invasiveness in an epidermal growth factor receptor–dependent manner, indicating that intercellular cross-talk in this inflamed setting reshapes both cell types and contributes to fibroblast-mediated joint destruction. In an ex vivo synovial tissue assay, most medications used to treat RA patients targeted HBEGF+ inflammatory macrophages; however, in some cases, medication redirected them into a state that is not expected to resolve inflammation. These data highlight how advances in our understanding of chronically inflamed human tissues and the effects of medications therein can be achieved by studies on local macrophage phenotypes and intercellular interactions.